A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension - Tabular View

Tracking Information

First Received Date ^ICMJE

May 12, 2006

Last Updated Date

December 19, 2007

Start Date ^ICMJE

April 2006

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Ocular discomfort

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00326092 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Official Title ^ICMJE

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Brief Summary

The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

Detailed Description

Study Phase

Phase II

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Condition ^ICMJE

Open-Angle Glaucoma
Ocular Hypertension

Intervention ^ICMJE

Drug: Brinzolamide/Timolol

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

September 2006

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)

Exclusion Criteria:

Under 18

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00326092

Responsible Party

Study ID Numbers ^ICMJE

C-05-49

Study Sponsor ^ICMJE

Alcon Research

Collaborators ^ICMJE

Investigators ^ICMJE

Study Director:

Julia White

Study Director

Information Provided By

Alcon Research

Verification Date

September 2007

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP